Accessibility

A+ A A-

Information Accessibility Statement
Site Colors Display (* Modern browsers like Chrome & Firefox) Normal Display Adjusted for color blinded Adjusted for hard vision Close

Outlines

Laboratory for Clinical and Applied Research

Dr. Michal Besser, Head

Research and clinical development of advanced cellular immune-therapy.

  1. Ongoing clinical studies – cell immune-therapies
  • TIL* for treatment of metastatic melanoma
  • TIL* for treatment of ovary cancer
  • CAR-T** for treatment of hematological malignancies

 

  1. Applied clinical research
  • Development of immune-therapy against mutations in tumor cells (Neo-Antigens)
  • Research and development of next generation TIL* treatment
  • Genetic engineering of lymphocytes with novel CAR-T** for treatment of various malignancies.
  • Molecular mechanism of apoptosis of melanoma cells
  • Research and development of skin substitutes for treatment of burns
  • Operation of GMP*** laboratory for development and production of cell

based therapies.

 

  • Tumor infiltrating lymphocytes
  • Chimeric antigen receptor
  • Good manufacturing practice

 

 

 

Research and Development Laboratory

Prof. Gal Markel, Head

Advanced clinical and applied research in various aspects of cancer immunology and immuno- therapy.

  1. Characterization of immune profile of patients for developing of customized treatments
  2. Identifying evasive mechanisms of tumors from the immune system as targets for developing new drugs.
  3. The influence of metabolism of the tumor on the immune system.
  4. Integrated data bases of cancer patients for research and development of new treatments.
  5. The role of microRNA in malignant development.